About Concentrics Research
Concentrics Research is a company based in Indianapolis (United States) founded in 1999 was acquired by Bindley Capital Partners in December 2002. The company has 47 employees as of December 31, 2021. Concentrics Research offers products and services including Rx-to-OTC Switch, Clinical Research, and Healthcare Market Research. Concentrics Research operates in a competitive market with competitors including United BioSource Corporation, Launch Therapeutics, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology and Ipsum, among others.
- Headquarter Indianapolis, United States
- Employees 47 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Concentrics Research, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
47
as on Dec 31, 2021
-
Acquired by
Bindley Capital Partners
(Dec 01, 2002)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Concentrics Research
Concentrics Research offers a comprehensive portfolio of products and services, including Rx-to-OTC Switch, Clinical Research, and Healthcare Market Research.
Service for transitioning prescription drugs to over-the-counter status.
Late-stage trials for drugs and devices in healthcare.
Regulated research for healthcare marketing strategies.
People of Concentrics Research
Unlock access to complete
Funding Insights of Concentrics Research
Detailed funding history for Concentrics Research
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Concentrics Research
Concentrics Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Bindley Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Bindley Capital Partners is engaged in private investment management.
|
Locked | Locked | Locked |
Investor details for Concentrics Research
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Concentrics Research
Investment portfolio details for Concentrics Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Concentrics Research
Detailed financials for Concentrics Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Concentrics Research Comparisons
Peer comparison for Concentrics Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Concentrics Research
Concentrics Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as United BioSource Corporation, Launch Therapeutics, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology and Ipsum, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical support services
|
|
| Locked | Locked | Locked |
Late-stage clinical development services are provided for biopharma companies.
|
|
| Locked | Locked | Locked |
Developer of pharmaceutical products for treating neurological diseases and chronic pain
|
|
| Locked | Locked | Locked |
Phase I-IV drug research and development services are provided.
|
|
| Locked | Locked | Locked |
Full-service CRO support for Phase II-IV clinical trials is provided.
|
Detailed competitors of Concentrics Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Concentrics Research
Complete news archive for Concentrics Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Concentrics Research
Concentrics Research was founded in 1999.
Concentrics Research is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
As of Dec 31, 2021, the latest employee count at Concentrics Research is 47.
Concentrics Research is a CRO with capabilities to conduct Rx-to-OTC Switch and Late-Stage (Phase II-IV) for the pharmaceutical, biotechnology, medical device, nutritional, and consumer healthcare product industries. The companys CRO service portfolio includes Protocol development, Project Management, Site Management, Investigator Meeting Planning and Conduct, Start-upKick-off Meetings, Clinical Monitoring, Data Collection (various EDC methods as well as paper), Data Management, Statistical analysis and Medical Writing. They offer their clinical development services for drugs, medical devices and dietary supplements. Concentrics Research has 3 major divisions - CRO, Site Management Organization (Concentrics Center for Research), and Concentrics Strategy Center (Initiates and Facilitates study conduct). The research site has capabilities to conduct Qualitative pre-testing for Rx-to-OTC Switch studies, Clinical research studies and Specialized custom marketing research.
Concentrics Research's top competitors include United BioSource Corporation, Xgene Pharmaceutical and Hikinger Pharmaceutical Technology.
Concentrics Research offers Rx-to-OTC Switch, Clinical Research, and Healthcare Market Research.
Concentrics Research has 1 investor. Key investors include Bindley Capital Partners.